Regulation of p53 and suppression of apoptosis by the soluble guanylyl cyclase/cGMP pathway in human ovarian cancer cells

Oncogene

Volumn 25, Issue 15, 2006, Pages 2203-2212

  Fraser, M ^a,b   Chan, S L ^a,b,c   Chan, S S L ^a,b   Fiscus, R R ^c   Tsang, B K ^a,b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^c and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

Apoptosis; cGMP; Ovarian cancer; p53; Soluble guanylyl cyclase

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 8 BROMO CYCLIC GMP; ATRIAL NATRIURETIC FACTOR; CASPASE 3; CYCLIC GMP; GENE PRODUCT; GUANYLATE CYCLASE; PIFITHRIN ALPHA; PROTEIN BAX; PROTEIN INHIBITOR; PROTEIN MDM2; PROTEIN P21; PROTEIN P53; SERINE; SMALL INTERFERING RNA; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; ARTICLE; CANCER CELL; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REPRESSION; HALF LIFE TIME; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; REGULATORY MECHANISM; UPREGULATION; WILD TYPE;

ADENOVIRIDAE; APOPTOSIS; ATRIAL NATRIURETIC FACTOR; BCL-2-ASSOCIATED X PROTEIN; BENZOTHIAZOLES; CASPASE 3; CASPASES; CYCLIC GMP; CYCLIC GMP-DEPENDENT PROTEIN KINASES; CYCLIN-DEPENDENT KINASE INHIBITOR P21; ENZYME ACTIVATION; ENZYME INHIBITORS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GUANYLATE CYCLASE; HALF-LIFE; HUMANS; MUTATION; OVARIAN NEOPLASMS; OXADIAZOLES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-MDM2; QUINOXALINES; RNA, SMALL INTERFERING; SERINE; SIGNAL TRANSDUCTION; THIAZOLES; TOLUENE; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

MAMMALIA; MURINAE;

EID: 33645744133     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209251     Document Type: Article

References (55)

1. Ashcroft M, Kubbutat MH, Vousden KH. (1999). Mol Cell Biol 19: 1751-1758.
2. Asselin E, Mills GB, Tsang BK. (2001). Cancer Res 61: 1862-1868.
3. Chan SL, Fiscus RR. (2003). Mol Hum Reprod 9: 775-783.
4. Chen HW, Jiang WS, Tzeng CR. (2001). Fertil Steril 75: 1163-1171.
5. Ciani E, Virgili M, Contestabile A. (2002). J Neurochem 81: 218-228.
6. Erster S, Mihara M, Kim RH, Petrenko O, Moll UM. (2004). Mol Cell Biol 24: 6728-6741.
7. Estevez AG, Spear N, Manuel SM, Barbeito L, Radi R, Beckman JS. (1998). Prog Brain Res 118: 269-280.
8. Falcone S, Mauro L, de Rose G, Paolucci C, Sciorati C, Ando S et al. (2002). Biochem J 366: 165-173.
9. Fiscus RR. (2002). Neurosignals 11: 175-190.
10. Fiscus RR, Tu AW, Chew SB. (2001). NeuroReport 12: 185-189.
11. Fiscus RR, Yuen JP, Chan SL, Kwong JH, Chew SB. (2002). J Card Surg 17: 336-339.
12. Flamigni F, Facchini A, Stanic I, Tantini B, Bonavita F, Stefanelli C. (2001). Biochem Pharmacol 62: 319-328.
13. Fraser M, Leung BM, Yan X, Dan HC, Cheng JQ, Tsang BK. (2003). Cancer Res 63: 7081-7088.
14. Garthwaite J, Southam E, Boulton CL, Nielsen EB, Schmidt K, Mayer B. (1995). Mol Pharmacol 48: 184-188.
15. Ha KS, Kim KM, Kwon YG, Bai SK, Nam WD, Yoo YM et al. (2003). FASEB J 17: 1036-1047.
16. Havrilesky L, Darcy M, Hamdan H, Priore RL, Leon J, Bell J et al. (2003). J Clin Oncol 21: 3814-3825.
17. Heinloth A, Brune B, Fischer B, Galle J. (2002). Atherosclerosis 162: 93-101.
18. Jadeski LC, Chakraborty C, Lala PK. (2003). Int J Cancer 106: 496-504.
19. Jadeski LC, Hum KO, Chakraborty C, Lala PK. (2000). Int J Cancer 86: 30-39.
20. Kerr JF, Winterford CM, Harmon BV. (1994). Cancer 73: 2013-2026.
21. Kim YM, Chung HT, Kim SS, Han JA, Yoo YM, Kim KM et al. (1999). J Neurosci 19: 6740-6747.
22. Komarov PG, Komarova EA, Kondratov RV, Christov-Tselkov K, Coon JS, Chernov MV et al. (1999). Science 285: 1733-1737.
23. LaCasse EC, Baird S, Korneluk RG, MacKenzie AE. (1998). Oncogene 17: 3247-3259.
24. Leitao MM, Soslow RA, Baergen RN, Olvera N, Arroyo C, Boyd J. (2004). Gynecol Oncol 93: 301-306.
25. Levine EL, Renehan A, Gossiel R, Davidson SE, Roberts SA, Chadwick C et al. (1995). Radiother Oncol 37: 1-9.
26. Li J, Feng Q, Kim JM, Schneiderman D, Liston P, Li M et al. (2001). Endocrinology 142: 370-380.
27. Liebermann DA, Hoffman B, Steinman RA. (1995). Oncogene 11: 199-210.
28. Luesley DM, Blackledge GR, Chan KK, Newton JR. (1986). Br J Obstet Gynaecol 93: 380-385.
29. Luesley DM, Chan KK, Newton JR, Blackledge GR. (1987). Br J Obstet Gynaecol 94: 461-466.
30. Mayo LD, Donner DB. (2001). Proc Natl Acad Sci USA 98: 11598-11603.
31. Mihara M, Erster S, Zaika A, Petrenko O, Chittenden T, Pancoska P et al. (2003). Mol Cell 11: 577-590.
32. Moro MA, Russel RJ, Cellek S, Lizasoain I, Su Y, Darley-Usmar VM et al. (1996). Proc Natl Acad Sci USA 93: 1480-1485.
33. Mulsch A, Bauersachs J, Schafer A, Stasch JP, Kast R, Busse R. (1997). Br J Pharmacol 120: 681-689.
34. Ogawara Y, Kishishita S, Obata T, Isazawa Y, Suzuki T, Tanaka K et al. (2002). J Biol Chem 277: 21843-21850.
35. Olesen SP, Drejer J, Axelsson O, Moldt P, Bang L, Nielsen-Kudsk JE et al. (1998). Br J Pharmacol 123: 299-309.
36. Olivier M, Eeles R, Hollstein M, Khan MA, Harris CC, Hainaut P. (2002). Hum Mutat 19: 607-614.
37. Orucevic A, Bechberger J, Green AM, Shapiro RA, Billiar TR, Lala PK. (1999). Int J Cancer 81: 889-896.
38. Panahian N, Maines MD. (2001). J Neurochem 76: 539-554.
39. Panahian N, Yoshiura M, Maines MD. (1999). J Neurochem 72: 1187-1203.
40. Persons DL, Yazlovitskaya EM, Pelling JC. (2000). J Biol Chem 275: 35778-35785.
41. Reap EA, Leslie D, Abrahams M, Eisenberg RA, Cohen PL. (1995). J Immunol 154: 936-943.
42. Sasaki H, Kotsuji F, Tsang BK. (2002). Gynecol Oncol 85: 339-350.
43. Sasaki H, Sheng Y, Kotsuji F, Tsang BK. (2000). Cancer Res 60: 5659-5666.
44. Sheets EE, Yeh J. (1997). Ann Med 29: 121-126.
45. Shieh SY, Ikeda M, Taya Y, Prives C. (1997). Cell 91: 325-334.
46. Siliciano JD, Canman CE, Taya Y, Sakaguchi K, Appella E, Kastan MB. (1997). Genes Dev 11: 3471-3481.
47. Suenobu N, Shichiri M, Iwashina M, Marumo F, Hirata Y. (1999). Arterioscler Thromb Vasc Biol 19: 140-146.
48. Tang CH, Grimm EA. (2004). J Biol Chem 279: 288-298.
49. Tejedo JR, Cahuana GM, Ramirez R, Esbert M, Jimenez J, Sobrino F et al. (2004). Endocrinology 145: 2319-2327.
50. Turner GA, Ellis RD, Guthrie D, Latner AL, Monaghan JM, Ross WM et al. (1982a). J Clin Pathol 35: 800-806.
51. Turner GA, Ellis RD, Guthrie D, Latner AL, Ross WM, Skillen AW. (1982b). Br J Obstet Gynaecol 89: 760-764.
52. Unger T, Sionov RV, Moallem E, Yee CL, Howley PM, Oren M et al. (1999). Oncogene 18: 3205-3212.
53. Waldman SA, Murad F. (1987). Pharmacol Rev 39: 163-196.
54. Xiao CW, Yan X, Li Y, Reddy SA, Tsang BK. (2003). Endocrinology 144: 623-630.
55. Zhou BP, Liao Y, Xia W, Zou Y, Spohn B, Hung MC. (2001). Nat Cell Biol 3: 973-982.